Target intelligence / Profile preview

Plaque biofilm matrix (null)

Target
null
Molecular classification
Other
01

Overview

The plaque biofilm matrix is not a single molecule or classical molecular target, but rather a complex, heterogeneous extracellular structure that surrounds bacterial communities in dental plaque[1][3][6][7]. It is composed primarily of exopolysaccharides (such as glucans and fructans produced by bacterial enzymes), extracellular DNA, proteins, lipids, and other macromolecules derived from both the resident microbiota and the host[1][3][6][7]. The matrix is essential for biofilm stability, functioning to maintain the spatial arrangement of microorganisms, protect against physical and chemical insults—including antimicrobials—and to mediate adhesion to tooth surfaces[1][2][3]. It facilitates the development of cariogenic (cavity-causing) and periodontopathogenic (gum disease–causing) communities by creating microenvironments with gradients in pH, nutrients, and oxygen[2][3]. The structure and composition of the matrix enable pathogens to persist in the oral cavity despite host defense mechanisms and therapeutic interventions[3][6]. Because it is not a specific molecular entity, the “plaque biofilm matrix” is not classified as a receptor, enzyme, or traditional druggable target, but targeting its structural components (notably exopolysaccharides and extracellular DNA) is an emerging strategy in oral disease management[1][3][6].

Other names
Dental plaque extracellular matrixOral biofilm matrixExtracellular polymeric substance of dental plaque
02

Mechanism of action

Disruption of exopolysaccharide network; Destabilization of matrix via enzymatic or chemical means; Reduction/neutralization of extracellular DNA (eDNA)

03

Biological functions

Biofilm structural integrityBacterial adhesionProtection against antimicrobials and host defensesFacilitates horizontal gene transferModulates local microenvironmentReservoir for nutrients
04

Disease associations

Infection (dental caries, periodontitis)Other (oral inflammatory disease)
05

Safety considerations

Matrix can confer increased bacterial resistance to antibiotics and antiseptics, making eradication difficultDisruption may release inflammatory or toxic bacterial components
06

Interacting drugs

Chlorhexidine

1 more in the full profile.

07

Biomarkers

Extracellular DNA (eDNA) contentGlucans and fructans (polysaccharides)Proxy: presence of key bacterial species (e.g., Streptococcus mutans)

Beyond the preview

Go deeper on Plaque biofilm matrix (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plaque biofilm matrix (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call